Weill Cornell Medicine’s Clinical and Translational Science Center has been awarded a two-year, $1.5 million NIH grant to investigate how social and biological factors help determine COVID-19 outcomes in New York City patients.
Women who receive COVID-19 mRNA vaccines produced by Pfizer-BioNTech or Moderna while in their third trimester of pregnancy generate a strong immune response and pass protective antibodies to their babies.
A study involving researchers from the College of Human Ecology and Weill Cornell Medicine estimates the incidence of elder mistreatment in New York state and advances understanding of key risk factors.
The degree to which the brain’s wiring aligns with its patterns of activity can vary with sex and age, and may be genetic, suggests a Weill Cornell Medicine-led study, which also finds that this alignment may have implications on cognition.
A two-year, $200,000 grant from the USDA and the Extension Foundation to Cornell researchers aims to help promote vaccine confidence and uptake in vulnerable communities in eight New York counties, both upstate and downstate.
As the nation looks to re-open, contact tracers will be needed to track and halt the spread of COVID-19. Gen Meredith, an expert in public health assessment, intervention development and workforce capacity building explains contact tracing and its importance.
The autoimmune disease lupus may be triggered by a defective process in the development of red blood cells (RBCs), according to a study led by researchers at Weill Cornell Medicine. The discovery could lead to new methods for classifying and treating patients with this disease.
Twenty-six students with businesses ranging from drinking water treatment to alternative medicine to kitchen robots, received fellowships to work on their businesses this summer.
A new study identifies the mechanism for tolerance to penicillin and related antibiotics in bacteria, findings that could lead to new therapies that boost the effectiveness of these treatments.
